EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia

Kellee N Parker, Sarah W Alexander, Lisa M Jacola, Kimberly A Buff, Kyobin Hwang, Elham Hashemi, Gregory Stoddard, Lindsay A Jibb iD

Pediatric Blood & Cancer · 2026

DOI: 10.1002/1545-5017.70156 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Kellee N Parker und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology/BMT, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Parents, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children's Oncology Group, University of Utah.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

B‐acute lymphoblastic leukemia (B‐ALL) is the most common pediatric cancer, and while most children in high‐resource settings are cured, therapy carries risks for long‐term toxicities. Understanding parents’ concerns about these late effects is essential to guide anticipatory support and inform evolving therapeutic approaches. Procedure In partnership with the national patient advocacy organization, Momcology, parents of children diagnosed with ALL between the ages 1 and 19 years completed an online survey. Parents selected up to five concerning potential late effects, rated the level of intensity of concern, and provided open‐text responses. Quantitative analyses examined associations with child and parent factors, and qualitative responses were analyzed using directed content analysis.

Results

The survey was completed by 442 parents of children with B‐ALL. The most frequently cited concerns were neurocognitive deficits (55%), secondary cancers (49%), mental health changes (36%), cardiotoxicity (31%), and infertility (30%). Concern for neurocognitive deficits persisted during and after therapy and was of greater concern among parents of younger children compared with older children (58% vs. 41%; p = 0.006). Concerns about neurocognitive effects correlated with concern for mental health and social changes (RR 1.86, 95% CI 1.40–2.47, RR 1.43, 1.03–1.98). Open‐text responses for all late effects of concern indicated enduring worry and impacts on family anxiety, daily life, and children's future opportunities.

Conclusions

Parents of children with B‐ALL report substantial, persistent concern about late effects, particularly neurocognitive impairment. Findings underscore the need for information and guidance for parents of children with ALL about late effects and the importance of integration of parent perspectives in defining ALL research priorities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ParentsPrecursor Cell Lymphoblastic Leukemia-LymphomaPrecursor B-Cell Lymphoblastic Leukemia-LymphomaHumansChildAdolescentFemaleChild, PreschoolMaleInfantYoung AdultAdultSurveys and Questionnaires

Stichwörter der Autor:innen

B‐acute lymphoblastic leukemiaadvocacylate effectsparental perspectivessurveysurvivorshiptoxicity

Autor:innen und Institutionen

  • Division of Hematology/Oncology/BMT, Department of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
  • Division of Hematology/Oncology/BMT, Department of Pediatrics, BC Children's Hospital, University of British Columbia, Vancouver, Canada.
  • Department of Psychology and Biobehavioral Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Momcology®, Saint Paul, Minnesota, USA.
  • Temerty Faculty of Medicine, University of Toronto, Toronto, Canada.
  • Child Health Evaluative Sciences, Hospital for Sick Children, Toronto, Canada.

ORCID-Profile: Lindsay A Jibb

Förderung

  • Children's Oncology Group
  • University of Utah

Zitieren

APA

Parker, K. N., Alexander, S. W., Jacola, L. M., Buff, K. A., Hwang, K., Hashemi, E., Stoddard, G., & Jibb, L. A. (2026). Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70156

Vancouver

Parker KN, Alexander SW, Jacola LM, Buff KA, Hwang K, Hashemi E, et al. Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70156

BibTeX
@article{Parker2026,
  author = {Parker, Kellee N and Alexander, Sarah W and Jacola, Lisa M and Buff, Kimberly A and Hwang, Kyobin and Hashemi, Elham and Stoddard, Gregory and Jibb, Lindsay A},
  title = {Characterizing Parental Concerns About Lasting Impacts of Treatment in Children With B‐Acute Lymphoblastic Leukemia},
  journal = {Pediatric Blood & Cancer},
  year = {2026},
  doi = {10.1002/1545-5017.70156}
}
Kostenlos starten →